Alector, Inc. (ALEC) research
Alector, Inc.- Sector
- Biotechnology
- Last price
- $2.01
- As of
Alector, Inc. (ALEC): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-06.
As of . Source: SEC EDGAR filings for ALEC. Method and limitations.
Share the ALEC intelligence card
See ALEC live in the terminal
Track ALEC's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live ALEC terminal, freeActive signals for ALEC
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 67% of ALEC (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +104% to ALEC (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +631% to ALEC (2026Q2)
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 67% of ALEC (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +631% to ALEC (2026Q2)
FREE, NO ACCOUNT
Every signal on ALEC, as it fires
You are seeing 5 of 16 signals recorded on ALEC since 2026-05-30.
The five above all landed on 2026-09-06. The other 11 were recorded on 4 other days. 11 of the 16 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in ALEC (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| D. E. Shaw & Co., Inc.CUSIP 014442107 · 2026Q2 | $5.9M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 014442107 · 2026Q2 | $4M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 014442107 · 2026Q2 | $2.1M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 014442107 · 2026Q2 | $1.9M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 014442107 · 2026Q2 | $786K | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 014442107 · 2026Q2 | $54K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, ALEC
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
ALEC against its peers
ALEC's operating margin of -741.3% ranks in the 28th percentile of 15 Biotechnology sub-industry peers, fiscal periods ending between 2025-09-30 and 2025-12-31.
| Metric | ALEC | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 21.0M USD | 19.4M USD | 53 | 15 |
| Operating margin | -741.3% | -221.7% | 28 | 15 |
| Net margin | -679.2% | -96.9% | 16 | 15 |
| Return on equity | -466.3% | -29.2% | 7 | 21 |
Peers (24): ADAG, ELDN, AVXL, NGEN, KROS, PLX, CHRS, IVVD, PEPG, NKTX, YDES, CGEN, IPHA, WHWK, TARA, SRZN, ALXO, CUE, NAGE, ORMP, ACOG, MSLE, CNTN, SLGL. Left out: VRXA (no annual filing). Fiscal periods ending between 2025-09-30 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (ALEC: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more ALEC signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to ALECand get the insider, 13F, options, and confluence read in one view.